← All trials
NCT06440746
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 23, 2023
- Primary completion
- Apr 9, 2027
- Completion date
- Dec 25, 2028
- First posted
- Jun 4, 2024
- Last posted
- Nov 19, 2024
- Enrollment
- 138
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- R-PharmLead sponsor
- Data Management 365 LLCCollaborator
- KeystatCollaborator
- R-PharmCollaborator
- Exacte Labs LLCCollaborator
- R-PharmOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.